En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

LumiraDx

LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use cloud-based platforms to integrate health system networks and transfer patient data.
Products Covid-19Summary
Close

Covid-19 LumiraDx

Clinical Laboratory

Point Of Care Diagnostic System
LumiraDx

LumiraDx Platform is a high sensitivity point of care (POC) diagnostic system that combines a small, portable instrument, microfluidic test strip, simple, standardized workflow, and seamless, secure digital connectivity to the Cloud and hospital IT systems. It leverages testing methodologies used in lab analyzer systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the POC. The LumiraDx Platform integrates several technologies and sample types into a single instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings. The LumiraDx Platform currently offers COVID-19 antigen and antibody test capabilities, with a pipeline of over 30 tests across a range of assay technologies, including enzyme, immunoassay, molecular and electrolyte assays.
More details

SARS-CoV-2 Ab Test
LumiraDx SARS-CoV-2 Ab Test

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.
More details

SARS-CoV-2 Ag Pool Test
LumiraDx SARS-CoV-2 Ag Pool Test

The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.
More details

SARS-CoV-2 Ag Test
LumiraDx SARS-CoV-2 Ag Test

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
More details

Point-Of-Care Testing

Point Of Care Diagnostic System
LumiraDx

LumiraDx Platform is a high sensitivity point of care (POC) diagnostic system that combines a small, portable instrument, microfluidic test strip, simple, standardized workflow, and seamless, secure digital connectivity to the Cloud and hospital IT systems. It leverages testing methodologies used in lab analyzer systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the POC. The LumiraDx Platform integrates several technologies and sample types into a single instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings. The LumiraDx Platform currently offers COVID-19 antigen and antibody test capabilities, with a pipeline of over 30 tests across a range of assay technologies, including enzyme, immunoassay, molecular and electrolyte assays.
More details
Close

About LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use cloud-based platforms to integrate health system networks and transfer patient data.

Recently updated

C-Reactive Protein Test
LumiraDx CRP Test

The LumiraDx CRP (C-Reactive Protein) test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the test delivers rapid, quantitative results in four minutes at the point of care.
More details

NT-proBNP Test
LumiraDx NT-proBNP Test

The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP levels in whole blood and plasma. It is the only quantitative direct fingerstick NT-proBNP test available today and delivers reliable, quantitative results in only 12 minutes at the point of need.
More details

HbA1c Test
LumiraDx HbA1c Test

The LumiraDx HbA1c test is an in vitro diagnostic test for the quantitative determination of hemoglobin A1c (IFCC mmol/mol and NGSP %) in human capillary and venous whole blood samples (EDTA). It is an automated in vitro diagnostic test for near-patient testing and intended for use with the LumiraDx Instrument.
More details

Clinical Laboratory

C-Reactive Protein Test
LumiraDx CRP Test

The LumiraDx CRP (C-Reactive Protein) test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the test delivers rapid, quantitative results in four minutes at the point of care.
More details

NT-proBNP Test
LumiraDx NT-proBNP Test

The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP levels in whole blood and plasma. It is the only quantitative direct fingerstick NT-proBNP test available today and delivers reliable, quantitative results in only 12 minutes at the point of need.
More details

HbA1c Test
LumiraDx HbA1c Test

The LumiraDx HbA1c test is an in vitro diagnostic test for the quantitative determination of hemoglobin A1c (IFCC mmol/mol and NGSP %) in human capillary and venous whole blood samples (EDTA). It is an automated in vitro diagnostic test for near-patient testing and intended for use with the LumiraDx Instrument.
More details

Point Of Care Diagnostic System
LumiraDx

LumiraDx Platform is a high sensitivity point of care (POC) diagnostic system that combines a small, portable instrument, microfluidic test strip, simple, standardized workflow, and seamless, secure digital connectivity to the Cloud and hospital IT systems. It leverages testing methodologies used in lab analyzer systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the POC. The LumiraDx Platform integrates several technologies and sample types into a single instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings. The LumiraDx Platform currently offers COVID-19 antigen and antibody test capabilities, with a pipeline of over 30 tests across a range of assay technologies, including enzyme, immunoassay, molecular and electrolyte assays.
More details

SARS-CoV-2 Ag Test
LumiraDx SARS-CoV-2 Ag Test

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
More details

SARS-CoV-2 Ag Pool Test
LumiraDx SARS-CoV-2 Ag Pool Test

The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.
More details

SARS-CoV-2 Ab Test
LumiraDx SARS-CoV-2 Ab Test

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.
More details

D-Dimer Test
LumiraDx D-Dimer Test

The LumiraDx D-Dimer Test is an easy to use fluorescence immunoassay designed to rapidly quantify D-Dimer levels in human whole blood and plasma at the point of care. It is the first quantitative micro-fluidic immunoassay of its kind, providing a precise and accurate D-Dimer result from a single direct fingerstick blood sample, in only six minutes.
More details

International Normalized Ratio (INR) Test
LumiraDx INR Test

The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the test delivers rapid results at the point of care.
More details

Point-Of-Care Testing

HbA1c Test
LumiraDx HbA1c Test

The LumiraDx HbA1c test is an in vitro diagnostic test for the quantitative determination of hemoglobin A1c (IFCC mmol/mol and NGSP %) in human capillary and venous whole blood samples (EDTA). It is an automated in vitro diagnostic test for near-patient testing and intended for use with the LumiraDx Instrument.
More details

Point Of Care Diagnostic System
LumiraDx

LumiraDx Platform is a high sensitivity point of care (POC) diagnostic system that combines a small, portable instrument, microfluidic test strip, simple, standardized workflow, and seamless, secure digital connectivity to the Cloud and hospital IT systems. It leverages testing methodologies used in lab analyzer systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the POC. The LumiraDx Platform integrates several technologies and sample types into a single instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings. The LumiraDx Platform currently offers COVID-19 antigen and antibody test capabilities, with a pipeline of over 30 tests across a range of assay technologies, including enzyme, immunoassay, molecular and electrolyte assays.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions